HeiQ, Swiss textile innovator, has developed an antiviral and antimicrobial treatment that is tested effective against Coronavirus (229E), according to the company.
The HeiQ Viroblock NPJ03, manufactured using vesicle and silver technology, restricts any stay or growth of bacteria and virus on the textile.
While the vesicle technology works by restricting the growth and shutting down any lipid-enveloped viruses, such as Coronavirus, the silver technology works in diminishing both bacteria and viruses.
The textile treatment has been proven to be effective against human Coronavirus in face masking testing. The innovation accelerates the antiviral log reduction from 2.90 of untreated face masks to 4.48.
Now that’s over 99.99 per cent reduction of virus infectivity (log reduction of 2 is equivalent to 100 times the effectiveness).
Carlo Centonze, HeiQ Group CEO, said “Virologist Dr. Thierry Pelet of HeiQ’s Scientific Advisory Board brought us a profound depth of knowledge and accelerated our efforts to address the urgent problem of a global pandemic.”
